To confirm the role of Cdt1 in checkpoint activation, we performed genetic knockdown of Cdt1 in CD40L/IL-21-stimulated CLL cells and treated them with MLN4924. The gene discussed is CDT1; the disease is B-cell chronic lymphocytic leukemia.